Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors
CONCLUSIONS: Anemia is common in patients with solid tumors; yet, compliance with NCCN Guidelines for evaluation and treatment of anemia remains low. There are opportunities to improve compliance with guidelines across the spectrum of cancer care.PMID:38489926 | DOI:10.6004/jnccn.2023.7108 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 15, 2024 Category: Cancer & Oncology Authors: Demetra Hypatia Hufnagel Lia Manfredi Bos Alaina Johnson Brown Lauren Shore Prescott Source Type: research

Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations
CONCLUSIONS: In this study, lack of order placement was a key reason for incomplete LCS steps. When orders were placed, patients who received navigation had higher rates of completion. Clinical team education and enhanced electronic health record processes to simplify order placement, coupled with patient navigation, may improve LCS in safety-net health care systems.PMID:38489927 | DOI:10.6004/jnccn.2023.7094 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 15, 2024 Category: Cancer & Oncology Authors: Sheena Bhalla Vijaya Natchimuthu Jessica L Lee Urooj Wahid Hong Zhu Noel O Santini Travis Browning Heidi A Hamann David H Johnson Hsienchang Chiu Simon J Craddock Lee David E Gerber Source Type: research

Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer
This report presents a case of a woman with metastatic NSCLC harboring a class II BRAF p.N486_P490del variant who had a sustained clinical response to combination therapy with dabrafenib and trametinib. This first report of the use of BRAF/MEK-targeted therapy for this variant in NSCLC supports consideration of such treatment for tumors with class II BRAF variants.PMID:38479107 | DOI:10.6004/jnccn.2024.7009 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 13, 2024 Category: Cancer & Oncology Authors: John A Sharp Daniel Jones Julia K Rotow Panos M Fidias Erin Bertino Dwight H Owen Source Type: research

Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry Study
CONCLUSIONS: This analysis in a large patient cohort of the BCI Registry confirms and extends previous findings on the significant decision-making impact of BCI on EET. Incorporating BCI into clinical practice resulted in changes in physician recommendations, increased physician confidence, improved patient satisfaction, and reduced patient concerns regarding the cost, drug safety, and benefit of EET.PMID:38437792 | DOI:10.6004/jnccn.2023.7087 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 4, 2024 Category: Cancer & Oncology Authors: Tara B Sanft Jenna Wong Brandon O'Neal Natalia Siuliukina Rachel C Jankowitz Mark D Pegram Jenny R Fox Yi Zhang Kai Treuner Joyce A O'Shaughnessy Source Type: research

Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients
CONCLUSIONS: We found that an educational video for patients receiving CAR T-cell therapy was feasible and acceptable. The educational video demonstrated promising preliminary effects on patient self-efficacy and decision satisfaction and warrants further study.PMID:38412605 | DOI:10.6004/jnccn.2024.70011 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - February 27, 2024 Category: Cancer & Oncology Authors: P Connor Johnson Tejaswini Dhawale Richard A Newcomb Ana Barata Kyle Karpinski Mitchell W Lavoie Dagny Vaughn Kathleen Hennessey David Schneider Hermioni L Amonoo Angelo Volandes Areej El-Jawahri Source Type: research

Oncologist Perceptions of Racial Disparity, Racial Anxiety, and Unconscious Bias in Clinical Interactions, Treatment, and Outcomes
CONCLUSIONS: Most oncologists rarely or never perceived racial anxiety/unconscious bias as adversely influencing clinical treatment or survival outcomes in non-White patients, and White oncologists were 85% more likely than non-White oncologists to perceive rare/nonexistent influence on referral of non-White patients to palliative care/hospice. The discrepancy between 62% of oncologists perceiving moderate to very high levels of racial anxiety/unconscious bias and 37% associating them with adverse influence on non-White patients shows a disconnect, especially among older oncologists (baby boomers), who were also least like...
Source: Journal of the National Comprehensive Cancer Network : JNCCN - February 27, 2024 Category: Cancer & Oncology Authors: Alexandrina Balanean Emily Bland Ajeet Gajra Yolaine Jeune-Smith Andrew J Klink Harlen Hays Bruce A Feinberg Source Type: research

Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients
CONCLUSIONS: We found that an educational video for patients receiving CAR T-cell therapy was feasible and acceptable. The educational video demonstrated promising preliminary effects on patient self-efficacy and decision satisfaction and warrants further study.PMID:38412605 | DOI:10.6004/jnccn.2024.70011 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - February 27, 2024 Category: Cancer & Oncology Authors: P Connor Johnson Tejaswini Dhawale Richard A Newcomb Ana Barata Kyle Karpinski Mitchell W Lavoie Dagny Vaughn Kathleen Hennessey David Schneider Hermioni L Amonoo Angelo Volandes Areej El-Jawahri Source Type: research